Planet Labs

Planet Labs reported record Q2/2027 revenue of $116.1m (+58% y/y), beating the consensus estimate. Adjusted earnings per share were $0.02 and adjusted EBITDA was $13.9m; both well above expectations. The defense and intelligence business grew by over 90% and accounted for around 70% of revenue; a one‑year contract with a European customer was confirmed. Management raised the annual guidance to $430–441m and is targeting positive adjusted EBITDA for the full year for the first time, but warned of a weaker Q3 outlook and temporarily negative adjusted EBITDA. » More on de.investing.com

Planet Labs reported adjusted earnings of 0.02 USD per share for Q2 2027 on revenue of 116.1 million USD, with both metrics above consensus. Revenue rose 58%, and defense/intelligence contracts accounted for roughly 70% of the quarter's revenue; the non‑GAAP gross margin was 59% and adjusted EBITDA was 13.9 million USD. Management raised the full‑year CapEx forecast (100–115 million USD) and expects lower revenue in Q3 and slightly negative adjusted EBITDA, but still projects full‑year revenue of 430–441 million USD and positive adjusted free cash flow. The stock fell sharply in regular trading but partially recovered after hours as investors weigh the strong results against the near‑term outlook. » More on de.investing.com

Planet Labs dropped about 8% despite announcing a one-year, seven-figure European defense and intelligence deal and receiving a Buy initiation from Berenberg. The contract is small relative to the company's earlier 8- and 9-figure government awards, so it does not materially change revenue or guidance. Short-dated options show defensive positioning ahead of quarterly results due after the close, and sector peers are also lagging, suggesting either stock-specific caution or broader rotation in space names. » More on finance.yahoo.com